WuXi XDC Cayman Shareholders to Vote on Annual Cap Boost on Oct. 25

MT Newswires Live10-09

Shareholders of WuXi XDC Cayman (HKG:2268) will meet on Oct. 25 to vote on the proposed revision of the annual caps under a 2023 agreement with controlling shareholder WuXi Biologics (Cayman), a Wednesday bourse filing said.

The contract under discussion is an antibodies master services agreement between the parties valid from Nov. 17, 2023, to Dec. 31, 2025.

The company is proposing to increase the annual caps for the years ending Dec. 31, 2024 and Dec. 31, 2025, to 2 billion yuan each from the current figures of 1.01 billion yuan and 895 million yuan, respectively.

Shares of the company closed nearly 9% higher on Wednesday.

Price (HKD): $22.55, Change: $-2.1, Percent Change: -8.52%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474244865?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-09 20:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474244865","market":"sh","top_or_hot":-1,"title":"WuXi XDC Cayman Shareholders to Vote on Annual Cap Boost on Oct. 25","media":"MT Newswires Live","content":"<html><body><p> Shareholders of WuXi XDC Cayman (HKG:2268) will meet on Oct. 25 to vote on the proposed revision of the annual caps under a 2023 agreement with controlling shareholder WuXi Biologics (Cayman), a Wednesday bourse filing said.</p><p>The contract under discussion is an antibodies master services agreement between the parties valid from Nov. 17, 2023, to Dec. 31, 2025.</p><p>The company is proposing to increase the annual caps for the years ending Dec. 31, 2024 and Dec. 31, 2025, to 2 billion yuan each from the current figures of 1.01 billion yuan and 895 million yuan, respectively.</p><p>Shares of the company closed nearly 9% higher on Wednesday.</p><p>Price (HKD): $22.55, Change: $-2.1, Percent Change: -8.52%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi XDC Cayman Shareholders to Vote on Annual Cap Boost on Oct. 25</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi XDC Cayman Shareholders to Vote on Annual Cap Boost on Oct. 25\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-09 20:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shareholders of WuXi XDC Cayman (HKG:2268) will meet on Oct. 25 to vote on the proposed revision of the annual caps under a 2023 agreement with controlling shareholder WuXi Biologics (Cayman), a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014674.SGD","symbol_name":"Nikko AM All China Equity A SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474244865","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474244865","pubTimestamp":1728475984,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shareholders of WuXi XDC Cayman (HKG:2268) will meet on Oct. 25 to vote on the proposed revision of the annual caps under a 2023 agreement with controlling shareholder WuXi Biologics (Cayman), a Wedne","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999014674.SGD":"Nikko AM All China Equity A SGD","BK4585":"ETF&股票定投概念","BK1141":"生命科学工具和服务","02269":"药明生物","02268":"药明合联","BK4588":"碎股","BK4526":"热门中概股","BK4023":"应用软件"},"translate_title":"WuXi XDC Cayman股东将于10月25日就年度上限提高进行投票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":0.9,"02269":0.7},"content_text":"Shareholders of WuXi XDC Cayman (HKG:2268) will meet on Oct. 25 to vote on the proposed revision of the annual caps under a 2023 agreement with controlling shareholder WuXi Biologics (Cayman), a Wednesday bourse filing said.The contract under discussion is an antibodies master services agreement between the parties valid from Nov. 17, 2023, to Dec. 31, 2025.The company is proposing to increase the annual caps for the years ending Dec. 31, 2024 and Dec. 31, 2025, to 2 billion yuan each from the current figures of 1.01 billion yuan and 895 million yuan, respectively.Shares of the company closed nearly 9% higher on Wednesday.Price (HKD): $22.55, Change: $-2.1, Percent Change: -8.52%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"Shareholding Changes","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474244865"}